The Conference Program is Revealed  

The 1st International Conference on Cancer Care Informatics (CCI 2018) will be held in Amman, Jordan in the period November 19-21, 2018 under the patronage of HRH Princess Ghida Talal, Chairperson King Hussein Cancer Foundation, and in Partnership with the University of the West of England, Bristol, UK.

About 150 scientists, researchers, technical experts and practitioners of Cancer Care Informatics from around the Globe are expected to join this conference participating and enriching R&D in Informatics-Empowered Cancer Care. 

All accepted papers will be published in the conference proceedings which will be submitted to IEEE Xplore.

Technical Sponsor

Keynote Speakers

PROF JOHN MATTICK

CEO Genomics England, and Chair of the 100K UK Genome Project, UK

Speech Title: 

The Transformation of Cancer Diagnosis, Treatment and Survival by Genome Analysis 

PROF ROLF APWEILER

Co-Director of European Bioinformatics Institute Cambridge, UK

Speech Title:

Bioinformatics Goes Translational: Infrastructural Challenges and Opportunities in Precision Medicine

LORD PAUL SCRIVEN

LORD PAUL SCRIVEN
UK House of Lords, UK Digital Health Initiative
Speech Title:
Putting the "I" into Cancer Care Informatics  - Ethical Questions and Issues: from a Patient Perspective

PROF ABDUALLAH KARADAG

Deputy Director of the TUBITAK Marmara Research Centre (MRC), Turkey
Speech Title:
Integrative Multiomics Analysis Meets Personalised-Medicine (P-Medicine): A Novel, Systematic, and Smart Healthcare Approach with a Focus on Cancer Care

PETER GOODHAND

Chief Executive Officer, Global Alliance for Genomics and Health
Toronto, Canada

Speech Title:
Global Sharing of Genomic and Health Data with Reference to Cancer

 

PROF JULIA WILSON

Associate Director, Wellcome Sanger Institute, Cambridge, UK
Speech Title:
Joint Keynote Speech with Peter Goodhand: “Global Sharing of Genomic and Health Data with Reference to Cancer”

 

 

Our Mission

We save lives by meeting the most critical needs in our communities
And investing in breakthrough research to prevent and cure cancer..

SIGN UP FOR OUR NEWSLETTER
Your email is safe, We don't spam!